A new study introduces an innovative, soft deployable airless wheel designed to facilitate exploration of the Moon’s lava tubes. Published in the December 2025 issue of Science Robotics, this work brings forward a novel approach to space travel and technology.

If you’re craving a unique holiday spectacle, look no further than a mesmerizing hour-long video of a humanoid robot sorting packages. The clip, shared by Figure AI’s founder Brett Adcock, highlights the robot’s promise as a game-changer for future warehouse operations.

Researchers are using advanced sensors and artificial intelligence to make prosthetic hands feel more natural. Amputees who once felt disconnected from their bionic limbs could soon gain a closer connection, thanks to new innovations in this field.

Construction of AstraZeneca’s new plant in Albemarle County is progressing swiftly. Local officials have been briefed on both the expected salaries for newly hired workers and the overall size of the operations, raising anticipation about the region’s economic benefit.

Scientists have unveiled a bionic hand that uses AI to assist amputees with everyday tasks. By integrating proximity and pressure sensors into a commercial prosthesis, they have enabled more intuitive movement. This approach aims to redefine how individuals with limb loss interact with their environment.

Imviva Biotech has revealed promising new data for its allogeneic CAR-T cell therapies, CTD402 and CTA311, at the 67th American Society of Hematology Annual Meeting. Early clinical findings suggest significant progress toward treating T-cell and B-cell malignancies, as well as severe aplastic anemia, through innovative approaches that may offer enhanced efficacy and widened patient access.

Sana Biotechnology has announced the successful use of fusogen technology to deliver potent in vivo gene editing of human hematopoietic stem cells (HSCs). Published in Nature Biotechnology, the preclinical research highlights systemic delivery in murine models, demonstrating promising precision for bone marrow–based therapies.

Nanjing Leads Biolabs Co., Ltd. presented new clinical data on LBL-034 at the 67th Annual Meeting of the American Society of Hematology (ASH) in Orlando. The results, featuring a median progression-free survival (PFS) trending beyond one year, spotlight a potential breakthrough in hematology.

BioAge Labs, Inc. has released interim results showing that its novel brain-penetrant NLRP3 inhibitor, BGE-102, was well-tolerated in early testing. Preliminary data suggests this once-daily oral medication could bring new options for conditions linked to inflammatory pathways.

AstraZeneca has unveiled a $2 billion plan to expand its manufacturing presence in Maryland, a move that marks its fourth U.S. commitment this year. The announcement highlights not only the company’s continued growth but also the broader impact such investments can have on America’s biotech landscape.

AI is poised to transform Mars missions with enhanced autonomy, safety measures, and deeper scientific insights. As the technology evolves, it stands to redefine the way humanity explores and sustains its presence on the Red Planet.

Cheese mold might seem mundane, but in a Vermont cave, it offers surprising lessons on evolution. As researchers examine how genes change within this unique environment, they uncover how even the most ordinary organisms can challenge our understanding of adaptation.

Forecasts reveal the global cell therapy packaging market is set to expand from USD 419.57 million in 2025 to USD 1274.31 million by 2034, reflecting an annual growth rate of 11.75%. Industry insights, drawn from Towards Packaging, point to accelerating demand in this evolving healthcare niche.

Sarasota is rolling out a new approach to mosquito management by utilizing drones in wooded areas. This initiative aims to be neighborhood-friendly, helping to reduce the local pest population with minimal disruption.

GC Genome and Asan Medical Center have published their collaborative findings on a blood-based colorectal cancer screening method. The study, now featured in The American Journal of Gastroenterology, highlights the promise of liquid biopsy techniques in improving early cancer detection.

Doctors and researchers have long recognized that our immune system has the potential to fight cancer. Recent breakthroughs have finally allowed that principle to evolve into powerful, immune-based therapies that bring renewed hope.

Bicara Therapeutics recently received an upgrade in its Relative Strength Rating, indicating improved technical performance. The biotech and pharma stock news signals a noteworthy uptick that investors may find significant.

DeepRoute.ai, an autonomous driving platform provider, is set to reach a major milestone of delivering 200,000 vehicles by the end of the year. After capturing 40% of the third-party NOA market in October, the company aims to expand further into robotaxi and next-generation autonomous applications.

AIRS Medical is making waves in diagnostic imaging through its award-winning AI-driven MRI solution, SwiftMR. With enhanced image quality and faster scan speeds, the company’s rapid expansion across Europe, the Middle East, and Africa signals its growing international influence.

Scientists have unveiled a spinal disc that replicates natural human disc motion, drawing on a landmark biomechanical study. This breakthrough could usher in a new era of motion-preserving spine care, potentially transforming treatments for degenerative back conditions.

CRISPR Therapeutics has crossed a key technical hurdle by surpassing an 80 Relative Strength Rating. The biotech company’s performance signals notable momentum in a competitive market space.